Surgical results of ahmed valve implantation with intraoperative bevacizumab injection in patients with neovascular glaucoma

Journal of Glaucoma

Volumn 21, Issue 5, 2012, Pages 331-336

  Ma, Kyoung Tak ^a   Yang, Jong Yun ^a,b   Kim, Ji Hyun ^b   Kim, Na Rae ^b   Hong, Samin ^b   Lee, Eun Suk ^b   Seong, Gong Je ^b   Kim, Chan Yun ^b  

^a Siloan Eye Hospital   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

Ahmed valve implantation; intraoperative intravitreous bevacizumab injection; neovascular glaucoma

Indexed keywords

BEVACIZUMAB;

ADULT; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; GLAUCOMA DRAINAGE IMPLANT; GLAUCOMA DRAINAGE IMPLANTATION; HUMAN; HYPHEMA; IMPLANTATION; INTRAOCULAR PRESSURE; INTRAOPERATIVE PERIOD; KERATOPATHY; MAJOR CLINICAL STUDY; MALE; NEOVASCULAR GLAUCOMA; OUTCOME ASSESSMENT; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RETINA DETACHMENT; RETROSPECTIVE STUDY; TRABECULECTOMY; TREATMENT FAILURE; VISUAL ACUITY; VITRECTOMY; VITREOUS HEMORRHAGE;

ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL, HUMANIZED; COMBINED MODALITY THERAPY; FEMALE; GLAUCOMA DRAINAGE IMPLANTS; GLAUCOMA, NEOVASCULAR; HUMANS; INTRAOCULAR PRESSURE; INTRAOPERATIVE CARE; INTRAVITREAL INJECTIONS; MALE; MIDDLE AGED; PROSTHESIS IMPLANTATION; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISUAL ACUITY;

EID: 84862175559     PISSN: 10570829     EISSN: 1536481X     Source Type: Journal    
DOI: 10.1097/IJG.0b013e31820e2fd0     Document Type: Article

References (25)

1. Vasudev D, Blair MP, Galasso J, et al. Intravitreal bevacizumab for neovascular glaucoma. J Ocul Pharmacol Ther. 2009; 25:453-458.
2. Casey R, Li WW. Factors controlling ocular angiogenesis. Am J Ophthalmol. 1997;124:521-529.
3. Tripathi RC, Li J, Tripathi BJ, et al. Increased level of vascular endothelial growth factor in aqueous humor of patients with neovascular glaucoma. Ophthalmology. 1998;105: 232-237.
4. Kim YG, Hong S, Lee CS, et al. Level of vascular endothelial growth factor in aqueous humor and surgical results of Ahmed glaucoma valve implantation in patients with neovascular glaucoma. J Glaucoma. 2009;18:443-447.
5. Rosenfeld PJ, Fung AE, Puliafito CA. Optical coherence tomography findings after an intravitreal injection of bevacizumab (avastin) for macular edema from central retinal vein occlusion. Ophthalmic Surg Lasers Imaging. 2005;36:336-339.
6. Rosenfeld PJ, Moshfeghi A, Puliafito CA. Optical coherence tomography findings after an intravitreal injection of bevacizumab (avastin) for neovascular age-related macular degeneration. Ophthalmic Surg Lasers Imaging. 2005;36:331-335.
7. Beutel J, Peters S, Luke M, et al. Bevacizumab as adjuvant for neovascular glaucoma. Acta Ophthalmol. 2010;88:103-109.
8. Costagliola C, Cipollone U, Rinaldi M, et al. Intravitreal bevacizumab (Avastin) injection for neovascular glaucoma: A survey on 23 cases throughout 12-month follow-up. Br J Clin Pharmacol. 2008;66:667-673.
9. Iliev ME, Domig D, Wolf-Schnurrbursch U, et al. Intravitreal bevacizumab (Avastin) in the treatment of neovascular glaucoma. Am J Ophthalmol. 2006;142:1054-1056.
10. Kahook MY, Schuman JS, Noecker RJ. Intravitreal bevacizumab in a patient with neovascular glaucoma. Ophthalmic Surg Lasers Imaging. 2006;37:144-146.
11. Moraczewski AL, Lee RK, Palmberg PF, et al. Outcomes of treatment of neovascular glaucoma with intravitreal bevacizumab. Br J Ophthalmol. 2009;93:589-593.
12. Yazdani S, Hendi K, Pakravan M. Intravitreal bevacizumab (Avastin) injection for neovascular glaucoma. J Glaucoma. 2007;16:437-439.
13. Yazdani S, Hendi K, Pakravan M, et al. Intravitreal bevacizumab for neovascular glaucoma: A randomized controlled trial. J Glaucoma. 2009;18:632-637.
14. Eid TM, Radwan A, el-Manawy W, et al. Intravitreal bevacizumab and aqueous shunting surgery for neovascular glaucoma: Safety and efficacy. Can J Ophthalmol. 2009;44:451-456.
15. Topouzis F, Coleman AL, Choplin N, et al. Follow-up of the original cohort with the Ahmed glaucoma valve implant. Am J Ophthalmol. 1999;128:198-204.
16. Hayreh SS. Neovascular glaucoma. Prog Retin Eye Res. 2007; 26:470-485.
17. Tanaka T, Matsuo T, Ohtsuki H. Aqueous vascular endothelial growth factor increases in anterior segment ischemia in rabbits. Jpn J Ophthalmol. 1998;42:85-89.
18. Davidorf FH, Mouser JG, Derick RJ. Rapid improvement of rubeosis iridis from a single bevacizumab (Avastin) injection. Retina. 2006;26:354-356.
19. Sawada O, Kawamura H, Kakinoki M, et al. Vascular endothelial growth factor in fellow eyes of eyes injected with intravitreal bevacizumab. Graefe Arch Clin Exp Ophthalmol. 2008;246:1379-1381.
20. Chalam KV, Gupta SK, Grover S, et al. Intracameral Avastin dramatically resolves iris neovascularization and reverses neovascular glaucoma. Eur J Ophthalmol. 2008;18:255-262.
21. Duch S, Buchacra O, Milla E, et al. Intracameral bevacizumab (Avastin) for neovascular glaucoma: A pilot study in 6 patients. J Glaucoma. 2009;18:140-143.
22. Grisanti S, Biester S, Peters S, et al. Intracameral bevacizumab for iris rubeosis. Am J Ophthalmol. 2006;142:158-160.
23. Wakabayashi T, Oshima Y, Sakaguchi H, et al. Intravitreal bevacizumab to treat iris neovascularization and neovascular glaucoma secondary to ischemic retinal diseases in 41 consecutive cases. Ophthalmology. 2008;115:1571-1580, 1580.e1571.
24. Jonas JB, Spandau UH, Schlichtenbrede F. Intravitreal bevacizumab for filtering surgery. Ophthalmic Res. 2007;39:121-122.
25. Kitnarong N, Chindasub P, Metheetrairut A. Surgical outcome of intravitreal bevacizumab and filtration surgery in neovascular glaucoma. Adv Ther. 2008;25:438-443.